PPIPT01022
Target Protein Information
| Protein_Name | Metastasis-suppressor KiSS-1 |
|---|---|
| Protein_Sequence | MNSLVSWQLLLFLCATHFGEPLEKVASVGNSRPTGQQLESLGLLAPGEQSLPCTERKPAATARLSRRGTSLSPPPESSGSPQQPGLSAPHSRQIPAPQGAVLVQREKDLPNYNWNSFGLRFGKREAAPGNHGRSAGRG |
| Organism_Source | Homo sapiens |
| Functional_Classification | Secreted metastasis-suppressor peptide |
| Cellular_Localization | Extracellular |
| Gene_Names | KISS1 |
| UniProt_ID | Q15726 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | biotinyl-PrP106-126 |
|---|---|
| Peptide_Sequence | TNMKHMAGAAAAGAVVGGLGGG |
| Peptide_Length | 22 |
| Peptide_SMILES | CSCC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)O)C(C)C)C(C)C |
| Chemical_Modification | None |
| Cyclization_Method | None |
| Linear/Cyclic | Cyclic |
| N-terminal_Modification | biotinyl |
| C-terminal_Modification | Free |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 1898.19 |
|---|---|
| Aliphatic_Index | 71.36364 |
| Aromaticity | 0.00000 |
| Average_Rotatable_Bonds | 2.81818 |
| Charge_at_pH_7 | 1.08860 |
| Isoelectric_point | 9.70200 |
|---|---|
| Number_of_Hydrogen_Bond_Acceptors | 29 |
| Number_of_Hydrogen_Bond_Donors | 27 |
| Topological_Polar_Surface_Area | 792.44000 |
| X_logP_energy | -11.66640 |
Interaction Information
| Affinity | KD=34.2 nM |
|---|---|
| Affinity_Assay | ELISA |
| PDB_ID | None |
| Type | Inhibitor |
| Structure | |
Reference Information
| Document_Type | Patent |
|---|---|
| Title | Kisspeptin peptides for use in the treatment of Alzheimer's disease, Creutzfeldt-Jakob disease or diabetes mellitus |
| Release_Year | 2011 |
| Patent_ID | EP2388012A1 |